Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure
Reserve your place

2017 Agenda currently in production - see 2016 highlights below 

To make sure you're first to get a look at this year’s iteration, pre-order the brochure here.

08:30 - 09:00
Panel: Thinking outside the box: the long drive towards a holistic and patient-centered value framework
  • Address the need for a system-wide framework to incorporate pharmacy, care management and interrelated health services for genuine value-based healthcare
  • Redefine the infrastructure for optimal data inputs to make full use of available sources of real world evidence
  • Embrace patient-centered value factors beyond effectiveness and side effects in order to differentiate their relative weight
  • Explore policies needed to ensure successful implementation of new patient centered payment models

Speaker Logo Robert Popovian Senior Director, US Government Relations Pfizer

Speaker Logo Shelly Ikeme Director, Global Head Market Access, Health Economics & Pricing Baxter

Moderator: Speaker Logo David Thompson Senior Vice President, RWE Consulting inVentiv Health

09:00 - 09:30
Generating Real World success: connecting commercial insights with evidence generation to drive market access & product adoption
  • Learn how to plan real-world research through the leveraging of commercial insights on external stakeholder needs
  • Develop commercialization plans with a strong foundation of evidence on product value
  • Plan and execute evidence generation and commercialization efforts hand-in-hand

Speaker Logo David Thompson Senior Vice President, RWE Consulting inVentiv Health

Speaker Logo Keith Kelly Managing Director & Head, Pricing & Market Access inVentiv Health

09:30 - 10:00
Beyond functional delivery – build Real World Evidence as your enterprise asset
  • Learn from an Intercept case study on how to elevate RWE from functional to enterprise value, moving HEOR beyond medical affairs and market access tactics
  • Understand what it takes to create a computing platform incorporating EMR, Lab Data, Social Networking etc and add value through algorithmic linkage and correlation

Speaker Logo Shailja Dixit Global Head, Health Outcomes & Real World Research Intercept Pharmaceuticals

09:30 - 10:00
Identify the challenges, complexities and eventual pay-off of HTA-based models
  • Understand how the HTA model could be translated to the complexities of the US market
  • Identify the financial and commercial pressures on American HTA initiatives and how pharma can help change this environment

Speaker Logo Clément François Vice President, U.S. HEOR Lundbeck

Speaker Logo Finn Børlum Kristensen Former Chairman EUnetHTA

09:30 - 10:00
Panel: Speed up approval while managing patient safety
  • Understand what 21st Century Cure legislation means for RWE inclusion and the use of patient-experience data across the development lifecycle
  • Discuss advances in approval policy frameworks – such as FDAISIA, BT pathways, PDUFA VI – to include “real world“ methods
  • Learn how PRO, innovative trial designs and expanded access accelerate cures for those with rare diseases while balancing safety concerns

Speaker Logo Edmond S. Malka Head, Epidemiology and Real World Data Sciences UCB

Speaker Logo Stacy Woeppel Deputy Director, Regulatory Affairs Sanofi-Pasteur

09:30 - 10:00
RWD Systems: Boost access, convergence, curation and analytics of increasingly large real-life data sets
  • Explore the best tools and internal capabilities to improve data management and quality
  • Leverage analytics to turn big data sets into smart systems

Speaker Logo Brande Ellis Senior Director, Center of Expertise, Global Patient Outcomes & RWE Lilly

09:30 - 10:00
Unlocking the secrets behind patient sentiments in Real World Data analytics
  • Case for integration of patient experiences and sentiments in real world evidence
  • Source-agnostic Real World Analytics platform for enhanced data integration
  • Way to expand market access stakeholders beyond payers and pharma

Speaker Logo Murali Krishnam Vice President, Life Sciences Saama Technologies

09:30 - 10:00
A view from the rare disease field: excellence in health outcomes and effectiveness research
  • Understand how to generate and demonstrate value of medications that treat rare conditions before and after market authorization
  • Draw on insights about the effectiveness of orphan medications where the pool of real-life patient insights is very limited
  • Realize how your methodologies can balance the need for evidence with the reality of engaging a population of disease patients

Speaker Logo Audra Boscoe Director, Health Outcomes Research Alexion Pharmaceuticals

Interactive Stakeholder Roundtables
09:30 - 10:00
RWE: Potential for Health System HEOR Partnerships
  • Leverage large patient populations as a foundation for your research
  • Discuss where health systems have EMR available data which is clinically significant
  • Understand how health systems often have risk stratified registries in multiple diseases, providing an opportunity for HEOR to segment patients

Speaker Logo Charles V. Pollack Jr. Professor of Emergency Medicine & Associate Provost Thomas Jefferson University

Speaker Logo Jerrold Penso Chief Medical & Quality Officer American Medical Group Association (AMGA)

The Pharma Opportunity: Medication Management in Risk Populations
  • Discuss why medication errors are a major factor in hospitalizations in certain populations
  • Explore how multiple chronic conditions require significant drug regimens
  • Discuss certain populations (Medicaid/Medicare) who are challenged to adhere to drug regimens

Speaker Logo Len Fromer Executive Medical Director Group Practice Forum

Speaker Logo John Walker former Chief Medical Officer Cornerstone Healthcare

Volume to Value-Based Care Delivery
  • Review alternative payment models as a hallmark of value-based programs
  • Understand how alternative payment models are being adopted by CMS and commercial payers
  • Hear how MACRA incorporates multiple value-based payment models

Speaker Logo David Carmouche SVP Ochsner Health System & President Ochsner Health Network

Speaker Logo Terry McGeeney President Care Accountability

Speaker Logo Kristen Shea Director of Strategy and Innovation Remedy Partners

Pre-order your event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown